Syngenta Introduces CruiserMaxx® Vibrance® Potato Insecticide/Fungicide Seed Treatment

Syngenta announced CruiserMaxx® Vibrance® Potato insecticide/fungicide seed treatment is now available for purchase, following its registration by the U.S. Environmental Protection Agency. It contains Vibrance fungicide seed treatment, the latest addition to the Syngenta Seedcare potato portfolio.

 

Led by Vibrance RootingPower, the link between stronger roots and higher yield potential, CruiserMaxx Vibrance Potato combines the power of three industry-leading fungicides for Rhizoctonia, Helminthosporium and Fusarium protection. Additionally, Cruiser® insecticide seed treatment provides exceptional protection against key insects, including Colorado potato beetles, aphids, potato leaf hopper and potato psyllid. It also delivers the Cruiser Vigor Effect, an increased level of plant vigor and health beyond the standard plant response to an insecticide.

 

“Potato growers looking to start strong with the most comprehensive insect and disease protection available for their young crops while boosting their root health can rely on CruiserMaxx Vibrance Potato,” said Kris Pauna, Seedcare commercial product lead, Syngenta. “This combination will help potato growers enhance germination, increase vigor and improve stand establishment, while improving size and tuber distribution to maximize quality yields.”

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.